- Home
- TSLX vs HCM Comparison
TSLX vs HCM Comparison
Compare TSLX & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSLX
- HCM
- Stock Information
- Founded
- TSLX 2010
- HCM 2000
- Country
- TSLX United States
- HCM Hong Kong
- Employees
- TSLX N/A
- HCM N/A
- Industry
- TSLX Investment Managers
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- TSLX Finance
- HCM Health Care
- Exchange
- TSLX Nasdaq
- HCM Nasdaq
- Market Cap
- TSLX 2.2B
- HCM 2.6B
- IPO Year
- TSLX 2014
- HCM N/A
- Fundamental
- Price
- TSLX $21.08
- HCM $15.52
- Analyst Decision
- TSLX Buy
- HCM Sell
- Analyst Count
- TSLX 9
- HCM 1
- Target Price
- TSLX $23.44
- HCM $13.75
- AVG Volume (30 Days)
- TSLX 578.9K
- HCM 34.4K
- Earning Date
- TSLX 11-04-2025
- HCM 08-07-2025
- Dividend Yield
- TSLX 9.64%
- HCM N/A
- EPS Growth
- TSLX N/A
- HCM N/A
- EPS
- TSLX 2.04
- HCM 0.53
- Revenue
- TSLX $464,512,000.00
- HCM $602,197,000.00
- Revenue This Year
- TSLX N/A
- HCM N/A
- Revenue Next Year
- TSLX N/A
- HCM $15.49
- P/E Ratio
- TSLX $10.36
- HCM $5.55
- Revenue Growth
- TSLX N/A
- HCM N/A
- 52 Week Low
- TSLX $18.58
- HCM $11.51
- 52 Week High
- TSLX $25.17
- HCM $19.50
- Technical
- Relative Strength Index (RSI)
- TSLX 33.08
- HCM 50.67
- Support Level
- TSLX $22.36
- HCM $14.40
- Resistance Level
- TSLX $23.19
- HCM $15.77
- Average True Range (ATR)
- TSLX 0.44
- HCM 0.32
- MACD
- TSLX -0.03
- HCM 0.10
- Stochastic Oscillator
- TSLX 0.47
- HCM 71.43
About TSLX Sixth Street Specialty Lending Inc.
Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.